Unknown

Dataset Information

0

The incidence of liver injury in Uyghur patients treated for TB in Xinjiang Uyghur autonomous region, China, and its association with hepatic enzyme polymorphisms nat2, cyp2e1, gstm1 and gstt1.


ABSTRACT:

Background and objective

Of three first-line anti-tuberculosis (anti-TB) drugs, isoniazid is most commonly associated with hepatotoxicity. Differences in INH-induced toxicity have been attributed to genetic variability at several loci, NAT2, CYP2E1, GSTM1and GSTT1, that code for drug-metabolizing enzymes. This study evaluated whether the polymorphisms in these enzymes were associated with an increased risk of anti-TB drug-induced hepatitis in patients and could potentially be used to identify patients at risk of liver injury.

Methods and design

In a cross-sectional study, 2244 tuberculosis patients were assessed two months after the start of treatment. Anti-TB drug-induced liver injury (ATLI) was defined as an ALT, AST or bilirubin value more than twice the upper limit of normal. NAT2, CYP2E1, GSTM1 and GSTT1 genotypes were determined using the PCR/ligase detection reaction assays.

Results

2244 patients were evaluated, there were 89 cases of ATLI, a prevalence of 4% 9 patients (0.4%) had ALT levels more than 5 times the upper limit of normal. The prevalence of ATLI was greater among men than women, and there was a weak association with NAT2*5 genotypes, with ATLI more common among patients with the NAT2*5*CT genotype. The sensitivity of the CT genotype for identifying patients with ATLI was 42% and the positive predictive value 5.9%. CT ATLI was more common among slow acetylators (prevalence ratio 2.0 (95% CI 0.95,4.20) )compared to rapid acetylators. There was no evidence that ATLI was associated with CYP2E1 RsaIc1/c1genotype, CYP2E1 RsaIc1/c2 or c2/c2 genotypes, or GSTM1/GSTT1 null genotypes.

Conclusions

In Xinjiang Uyghur TB patients, liver injury was associated with the genetic variant NAT2*5, however the genetic markers studied are unlikely to be useful for screening patients due to the low sensitivity and low positive predictive values for identifying persons at risk of liver injury.

SUBMITTER: Xiang Y 

PROVIDER: S-EPMC3900431 | biostudies-literature | 2014

REPOSITORIES: biostudies-literature

altmetric image

Publications

The incidence of liver injury in Uyghur patients treated for TB in Xinjiang Uyghur autonomous region, China, and its association with hepatic enzyme polymorphisms nat2, cyp2e1, gstm1 and gstt1.

Xiang Yang Y   Ma Long L   Wu Weidong W   Liu Wei W   Li Yongguang Y   Zhu Xia X   Wang Qian Q   Ma Jinfeng J   Cao Mingqin M   Wang Qian Q   Yao Xuemei X   Yang Lei L   Wubuli Atikaimu A   Merle Corinne C   Milligan Paul P   Mao Ying Y   Gu Jiayi J   Xin Xiumei X  

PloS one 20140123 1


<h4>Background and objective</h4>Of three first-line anti-tuberculosis (anti-TB) drugs, isoniazid is most commonly associated with hepatotoxicity. Differences in INH-induced toxicity have been attributed to genetic variability at several loci, NAT2, CYP2E1, GSTM1and GSTT1, that code for drug-metabolizing enzymes. This study evaluated whether the polymorphisms in these enzymes were associated with an increased risk of anti-TB drug-induced hepatitis in patients and could potentially be used to ide  ...[more]

Similar Datasets

| S-EPMC2630413 | biostudies-literature
| S-EPMC6002464 | biostudies-literature
| S-EPMC8288110 | biostudies-literature
| S-EPMC8082558 | biostudies-literature
| S-EPMC3376678 | biostudies-literature
| S-EPMC4761799 | biostudies-literature
| S-EPMC6760517 | biostudies-literature
| S-EPMC8402352 | biostudies-literature
| S-EPMC4299568 | biostudies-literature
| S-EPMC3321349 | biostudies-other